Precio Kindstar Globalgene Technology, Inc. (09960.HK)

Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. The company is headquartered in Wuhan, Hubei and currently employs 3,162 full-time employees. The company went IPO on 2021-07-16. The firm includes nine segments. The Hematology Testing segment includes testing services related to blood diseases. The Genetic Diseases and Rare Diseases segment includes testing services from the rare disease. The Infectious Diseases segment includes testing services from the infection department. The Oncology segment includes testing related to oncology diseases. The Neurology segment includes testing services related to neurological diseases. The Maternity-Related Diseases segment includes testing services related to maternity. The Routine Testing segment conducts routine tests for the doctors’ daily diagnoses. The Scientific Research Services and Cro segment includes research and development services. The Others segment provides other miscellaneous testing services.